CareLit · DOI-Nachweis · Aktuelle Neurologie
Preliminary results of a Phase II study: combined systemic polychemotherapy and intrathecal treatment with liposomal cytarabine in patients with primary CNS lymphoma ≥60 years
DOI 10.1055/s-0029-1238747
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Jürgens, H Pels, M Reiser, A Engert, U Herrlinger, M Lamprecht, G Egerer, M Vogt-Schaden, P Hau, G Schackert, H Reichmann, F Kroschinsky, IGH Schmidt-Wolf, U Schlegel
ZeitschriftAktuelle Neurologie
Ausgabe10/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objectives: To evaluate response rate, event free survival, overall survival, and toxicity in primary central nervous system lymphoma (PCNSL) after a combined systemic and intrathecal chemotherapy in patients ≥60 years. Patients and methods: From 11/2005 to 03/2009, 70 patients with PCNSL (median age 67 years) were enrolled in phase II study evaluating systemic polychemotherapy combined with intrathecal application…
Zitieren
Zitierempfehlung
A Jürgens, H Pels, M Reiser, A Engert, U Herrlinger, M Lamprecht, G Egerer, M Vogt-Schaden, P Hau, G Schackert, H Reichmann, F Kroschinsky, IGH Schmidt-Wolf, U Schlegel (2009) Preliminary results of a Phase II study: combined systemic polychemotherapy and intrathecal treatment with liposomal cytarabine in patients with primary CNS lymphoma ≥60 years. Aktuelle Neurologie (10). https://doi.org/10.1055/s-0029-1238747
Mit CareLit weiterarbeiten